Physician profile
Mark A Workman
NPI 1447238415
$2,974.94
in general payments reported to CMS, 2019-2025
12 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $234 · 2021: $549 · 2022: $188 · 2023: $322 · 2024: $417 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,524.76 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Collegium Pharmaceutical, INC. | $415.72 | 2019-2024 | Xtampza |
| Medtronic USA, INC. | $372.76 | 2019-2020 | |
| Si-Bone, INC. | $266.78 | 2021-2025 | |
| Vertos Medical, INC. | $155.07 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $64.90 | 2024-2025 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $63.42 | 2020-2021 | |
| Sentynl Therapeutics, INC. | $33.79 | 2019 | |
| Spinal Simplicity, LLC | $25.83 | 2023 | Ha Minuteman G3-R |
| Surgalign Spine Technologies, INC. | $18.72 | 2019 | |
| Relievant Medsystems, INC. | $17.88 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Workman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.